Literature DB >> 3071483

Islet cell and insulin autoantibodies in subjects at high risk for development of type 1 (insulin-dependent) diabetes mellitus: the Lyon family study.

C Thivolet1, B Beaufrére, H Bétuel, L Gebuhrer, P Chatelain, A Durand, J Tourniaire, R François.   

Abstract

Genetic determination as well as prospective analysis of islet cell autoantibodies and autoantibodies to insulin were conducted in a population of 479 first degree relatives of 174 Type 1 (insulin-dependent) diabetic patients. Analysis of HLA haplotypes within families illustrated the high frequency of DR3 and DR4 alleles with preferential transmission from parent to both affected and unaffected offspring. DR4 was preferentially associated with DQw3.2 (TA10-) in 60/73 (82.2%) patients and 101/127 (79.5%) relatives. Relatives have been followed for a period of 800 subject-years. Twenty-two out of 430 relatives (5.1%) were found islet cell antibodies (ICA-IgG) positive. Seven sera with low titres became negative 6 months later at two different determinations. Fifteen sera ICA-IgG and ICA-protein A positive with high titres remained positive thereafter. Half of the ICA positive relatives were also found insulin autoantibodies (IAA) positive. All but 3 ICA negative relatives did not have IAA in their sera. Analysis of IAA specificity with competition experiments indicated that most antibodies recognised epitopes shared between human and pork insulins while four were specific for human insulin determinants. Analysis of class I and class II HLA antigen distribution indicated no particular allelic restriction in antibody positive individuals. Metabolic status of antibody positive relatives was determined with oral and intravenous charge of glucose. Two haplo-identical DR3-DQw2 brothers became diabetic during the study. One child and one mother both with DR4-DQw3.2 became intolerant to glucose. Each of these relatives had high titre ICA prior to metabolic deterioration.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3071483     DOI: 10.1007/bf00274776

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  25 in total

1.  Identification of a polymorphic variant associated with HLA-DQw3 and characterized by specific restriction sites within the DQ beta-chain gene.

Authors:  S J Kim; S L Holbeck; B Nisperos; J A Hansen; H Maeda; G T Nepom
Journal:  Proc Natl Acad Sci U S A       Date:  1985-12       Impact factor: 11.205

2.  Islet-cell antibodies in diabetes mellitus with autoimmune polyendocrine deficiencies.

Authors:  G F Bottazzo; A Florin-Christensen; D Doniach
Journal:  Lancet       Date:  1974-11-30       Impact factor: 79.321

Review 3.  HLA and disease 1982--a survey.

Authors:  A Svejgaard; P Platz; L P Ryder
Journal:  Immunol Rev       Date:  1983       Impact factor: 12.988

4.  Beta-cell damage in diabetic insulitis: are we approaching a solution?

Authors:  G F Bottazzo
Journal:  Diabetologia       Date:  1984-04       Impact factor: 10.122

5.  First-degree relatives of patients with type I diabetes mellitus. Islet-cell antibodies and abnormal insulin secretion.

Authors:  S Srikanta; O P Ganda; A Rabizadeh; J S Soeldner; G S Eisenbarth
Journal:  N Engl J Med       Date:  1985-08-22       Impact factor: 91.245

6.  Fluctuating islet-cell autoimmunity in unaffected relatives of patients with insulin-dependent diabetes.

Authors:  K M Spencer; A Tarn; B M Dean; J Lister; G F Bottazzo
Journal:  Lancet       Date:  1984-04-07       Impact factor: 79.321

7.  Autoimmunity to insulin, beta cell dysfunction, and development of insulin-dependent diabetes mellitus.

Authors:  S Srikanta; A T Ricker; D K McCulloch; J S Soeldner; G S Eisenbarth; J P Palmer
Journal:  Diabetes       Date:  1986-02       Impact factor: 9.461

8.  Insulin-dependent diabetes--associated HLA-D region encoded determinants.

Authors:  F H Bach; S S Rich; J Barbosa; M Segall
Journal:  Hum Immunol       Date:  1985-02       Impact factor: 2.850

9.  Factors associated with early remission of type I diabetes in children treated with cyclosporine.

Authors:  P F Bougneres; J C Carel; L Castano; C Boitard; J P Gardin; P Landais; J Hors; M J Mihatsch; M Paillard; J L Chaussain
Journal:  N Engl J Med       Date:  1988-03-17       Impact factor: 91.245

10.  Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. National Diabetes Data Group.

Authors: 
Journal:  Diabetes       Date:  1979-12       Impact factor: 9.461

View more
  8 in total

1.  Excess of maternal HLA-DR3 antigens in HLA DR3,4 positive type 1 (insulin-dependent) diabetic patients.

Authors:  I Deschamps; J Hors; F Clerget-Darpoux; E Gardais; J J Robert; A Marcelli-Berge; H Lestradet; J Dausset
Journal:  Diabetologia       Date:  1990-07       Impact factor: 10.122

2.  No difference in the parental origin of susceptibility HLA class II haplotypes among Norwegian patients with insulin-dependent diabetes mellitus.

Authors:  D E Undlien; H E Akselsen; G Joner; K Dahl-Jorgensen; O Aagenaes; O Sovik; E Thorsby; K S Rønningen
Journal:  Am J Hum Genet       Date:  1995-12       Impact factor: 11.025

3.  Glutamic acid decarboxylase (GAD) autoantibodies are additional predictive markers of type 1 (insulin-dependent) diabetes mellitus in high risk individuals.

Authors:  C H Thivolet; M Tappaz; A Durand; J Petersen; A Stefanutti; P Chatelain; B Vialettes; W Scherbaum; J Orgiazzi
Journal:  Diabetologia       Date:  1992-06       Impact factor: 10.122

4.  Autoantibodies and genetic factors associated with the development of type 1 (insulin-dependent) diabetes mellitus in first degree relatives of diabetic patients.

Authors:  C Thivolet; B Beaufrère; L Geburher; P Chatelain; J Orgiazzi; R François
Journal:  Diabetologia       Date:  1991-03       Impact factor: 10.122

5.  Detection of autoantibodies against islet amyloid polypeptide in human serum. Lack of association with type 1 (insulin-dependent) diabetes mellitus, or with conditions favouring amyloid deposition in islets. The Belgian Diabetes Registry.

Authors:  F K Gorus; J C Sodoyez; D G Pipeleers; B Keymeulen; A Foriers; C F Van Schravendijk
Journal:  Diabetologia       Date:  1992-11       Impact factor: 10.122

6.  Insulin prevents adoptive cell transfer of diabetes in the autoimmune non-obese diabetic mouse.

Authors:  C H Thivolet; E Goillot; P Bedossa; A Durand; M Bonnard; J Orgiazzi
Journal:  Diabetologia       Date:  1991-05       Impact factor: 10.122

7.  Influence of affinity of antibodies upon their detection by liquid phase radiobinding assay and solid phase enzyme linked immunosorbent assay. Demonstration using monoclonal antibodies raised against rDNA human proinsulin.

Authors:  J C Sodoyez; M Koch; I Lemaire; F Sodoyez-Goffaux; A Rapaille; C François-Gérard; D Sondag
Journal:  Diabetologia       Date:  1991-07       Impact factor: 10.122

8.  HLA-DQ beta-chain restriction fragment length polymorphism as a risk marker in type 1 (insulin-dependent) diabetes mellitus: a Finnish family study.

Authors:  H Reijonen; J Ilonen; M Knip; B Michelsen; H K Akerblom
Journal:  Diabetologia       Date:  1990-06       Impact factor: 10.122

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.